Off-Label Cancer Studies Only Covered When Drugs Are Not Free, CMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Medicare & Medicaid Services will only cover the cost of drugs in off-label colorectal cancer studies when the therapies are not otherwise free, Administrator Mark McClellan said Jan. 12